Table 2 The decrease in the HBV DNA levels after TDF treatment.

From: Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads

Compared time points

Mean

STD

p value*

24 vs. 28 weeks

2.75

1.19

<0.0001

28 vs. 32 weeks

1.08

0.92

<0.0001

32 vs. 36 weeks

0.57

0.59

<0.0001

36 vs. 40 weeks

0.49

0.58

<0.0001

  1. *p < 0.05 indicates that the serum HBV DNA levels changed significantly between two time points.
Back to article page